How to Track FDA Approval Risk Before a PDUFA Date
Learn a practical way to monitor FDA approval risk before a PDUFA date by watching evidence, labeling, safety, manufacturing, and company updates.
Blog Tag
21 articles tagged with FDA. The newest post is from Jul 6, 2026.
Learn a practical way to monitor FDA approval risk before a PDUFA date by watching evidence, labeling, safety, manufacturing, and company updates.
FDA wants to use real-time data and AI to speed up clinical trials. Here is what the proposal could mean for biotech timelines, capital efficiency, and investors.
Learn how to recognize regulatory language in biotech news, including filing, review, approval, and delay terminology.
Learn how to judge whether an FDA-related biotech update is important enough to matter for stock movement and catalyst tracking.
Learn what a monoclonal antibody is, why it matters in biotech, and how antibody drugs shape development, approval, and market competition.
Learn what label expansion means in biotech, why it matters for commercial growth, and how new indications can extend a product's life.
Learn what a biosimilar is, why it matters for biologic competition, and how biosimilar news can affect original drug markets.
Learn what a surrogate endpoint is, why it matters in biotech, and how it supports faster regulatory decisions and accelerated approval.
Learn what post-marketing studies are, why the FDA requires them, and how they affect biotech news after approval.
Learn what accelerated approval means in biotech, why it matters for serious diseases, and how it depends on surrogate endpoints and post-marketing studies.
Learn what priority review means at the FDA, why it matters for biotech approval timelines, and how it can shorten a review cycle.
Learn what fast track designation means in biotech, why it matters for serious diseases, and how it can support a quicker development path.
Learn what breakthrough therapy designation means, why it matters in biotech, and how it can speed development and regulatory interaction.
Learn what orphan drug designation means, why it matters for rare disease biotech programs, and how it affects development and commercialization.
Learn what an IND is, why it matters in biotech drug development, and how it signals the beginning of human clinical testing.
Learn why biotech is naturally suited to event-driven news products, and why catalysts, timelines, and regulatory milestones create strong product value.
Learn what a catalyst means in biotech news, why catalyst events move stocks, and how investors use catalyst alerts to track trials and FDA milestones.
Learn what a catalyst window is, why timing matters in biotech news, and how investors use windows to monitor trial, FDA, and earnings events.
Learn what a CRL is, why the FDA issues Complete Response Letters, and how a CRL can affect biotech stocks, timelines, financing, and pipeline strategy.
Understand what PDUFA means, how a PDUFA date works, and why this FDA milestone is one of the most important events in biotech news and investing.
Learn what a biotech catalyst is, why catalyst-driven news moves biotech stocks, and how investors use catalyst alerts to follow FDA and clinical events.